
Cipla gains 5% on USFDA nod for generic cancer drug; set to launch in the US
Elara had already factored in approximately $20 million in revenue from gAbraxane in the US for FY26. While 3–4 generic players are currently active in…

Elara had already factored in approximately $20 million in revenue from gAbraxane in the US for FY26. While 3–4 generic players are currently active in…

There is still no clarity on whether the 25% tariffs on automobile imports will also be paused or not, even as US President Donald Trump…

On Friday, market tech analysts Mitessh Thakkar and Shrikant Chouhan recommended these stocks for the short term.

Crypto industry participants argued that because DeFi exchanges don’t act as intermediaries, they don’t have visibility into who their users are, making it impossible to…

Samvardhana Motherson via its subsidiary SMRP BV, has proactively initiated a series of transformative measures in Central and Western Europe, the company said in an…

The current proposal has been put in abeyance and there will be a fresh exercise in consultation with TCIL, Bharti Hexacom said in an exchange…

Kotak Institutional Equities has downgraded Muthoot Finance to “add” from its earlier rating of “buy” and has also trimmed its price target to ₹2,250 from…

The deepening worries over President Donald Trump’ s trade war helped pull Japan’s Nikkei 225 share index down 5.6%. On Thursday, the S&P 500 tumbled…

Out of the 48 analysts that have coverage on TCS, 34 still have a “buy” rating on the stock, 11 say “hold”, while three have…

Sensex Today | Stock Market LIVE Updates: Indian markets closed in negative territory on Wednesday, weighed down by tariff-related uncertainty from the US, with IT…